CDRH Turns In Strong Performance For Premarket Reviews In Fiscal Year 2001
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Device Evaluation maintained 510(k) total review times near statutory timelines in fiscal year 2001, despite the increasing strain on center resources.